Chinese Journal of Pharmacovigilance ›› 2020, Vol. 17 ›› Issue (12): 883-884.
DOI: 10.19803/j.1672-8629.2020.12.07

Previous Articles     Next Articles

"Double Classification" Management of Prescription Drugs and Non-prescription Drugs in China based on British System

TIAN Chunhua, XIA Dongsheng   

  1. Center for Drug Reevaluation,NMPA,Beijing 100022,China
  • Received:2020-07-17 Revised:2020-12-07 Online:2020-12-15 Published:2020-12-07

Abstract: Objective To analyze the way in which different categories of the same drugs are managed in the drug classification management system in Britain so as to provide reference for the "double classification " management of prescription drugs and non-prescription drugs in China.Methods The similarities and differences in ways of managing prescription drugs and non-prescription drugs between Britain and China were analyzed.Results and Conclusion "Double classification " is consistent with the properties of drugs in China. We can learn from the classification management system and experience of Britain to improve China's drug classification management system.

Key words: non-prescription drugs, "double classification" management, drug classification management system in Britain

CLC Number: